Evidence map›Paper›PMID 31110221›Full record

ArticleNature communications2019

Methylation and PTEN activation in dental pulp mesenchymal stem cells promotes osteogenesis and reduces oncogenesis.

Wen-Ching Shen, Yung-Chih Lai, Ling-Hui Li, Kolin Liao, Hung-Chang Lai, Shou-Yen Kao, John Wang, Cheng-Ming Chuong, Shih-Chieh Hung

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 173 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Identifying TNFSF4Stem cell research & therapy · 2025
    Article
  17. Review
  18. PRMT7-Mediated PTEN Activation Enhances Bone Regeneration in Female Mice.International journal of molecular sciences · 2025
    Article
  19. Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Wen-Ching ShenDrug Development Center, Institute of New Drug Development, Institute of Biomedical Sciences, China Medical University, Taichung, 404, Taiwan.
Yung-Chih LaiIntegrative Stem Cell Center, Department of Orthopaedics, China Medical University Hospital, Taichung, 404, Taiwan.
Ling-Hui LiInstitute of Biomedical Sciences, Academia Sinica, Taipei, 105, Taiwan.
Kolin LiaoDrug Development Center, Institute of New Drug Development, Institute of Biomedical Sciences, China Medical University, Taichung, 404, Taiwan.
Hung-Chang LaiDepartment of Stomatology, Taipei Veterans General Hospital, Taipei, 112, Taiwan.
Shou-Yen KaoDepartment of Stomatology, Taipei Veterans General Hospital, Taipei, 112, Taiwan.
John WangDepartment of Pathology, China Medical University Hospital, Taichung, 404, Taiwan.
Cheng-Ming ChuongIntegrative Stem Cell Center, Department of Orthopaedics, China Medical University Hospital, Taichung, 404, Taiwan.
Shih-Chieh HungDrug Development Center, Institute of New Drug Development, Institute of Biomedical Sciences, China Medical University, Taichung, 404, Taiwan. hung3340@gmail.com.ORCID http://orcid.org/0000-0003-1813-4616
China Medical University · TWInstitute of Biomedical Sciences, Academia Sinica · TWNational Yang Ming Chiao Tung University · TWTaipei Veterans General Hospital · TWUniversity of Southern California · US

Funding

Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan) 105-2314-B-039 -013 -MY3Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan) 107-2321-B-039 -005 -
6 · The paper itself

Abstract

Lineage commitment and tumorigenesis, traits distinguishing stem cells, have not been well characterized and compared in mesenchymal stem cells derived from human dental pulp (DP-MSCs) and bone marrow (BM-MSCs). Here, we report DP-MSCs exhibit increased osteogenic potential, possess decreased adipogenic potential, form dentin pulp-like complexes, and are resistant to oncogenic transformation when compared to BM-MSCs. Genome-wide RNA-seq and differential expression analysis reveal differences in adipocyte and osteoblast differentiation pathways, bone marrow neoplasm pathway, and PTEN/PI3K/AKT pathway. Higher PTEN expression in DP-MSCs than in BM-MSCs is responsible for the lineage commitment and tumorigenesis differences in both cells. Additionally, the PTEN promoter in BM-MSCs exhibits higher DNA methylation levels and repressive mark H3K9Me2 enrichment when compared to DP-MSCs, which is mediated by increased DNMT3B and G9a expression, respectively. The study demonstrates how several epigenetic factors broadly affect lineage commitment and tumorigenesis, which should be considered when developing therapeutic uses of stem cells.

Indexed as

AdipocytesAdultAgedAged, 80 and overBone Marrow CellsBone NeoplasmsCarcinogenesisCell DifferentiationCells, CulturedChildDental PulpDNA (Cytosine-5-)-MethyltransferasesDNA MethylationDNA Methyltransferase 3BEpigenesis, GeneticGene Expression Regulation, NeoplasticDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3BEHMT2 protein, humanHistocompatibility AntigensHistone-Lysine N-MethyltransferasePTEN PhosphohydrolasePTEN protein, human

Identifiers

PMID31110221
PMCPMC6527698
OpenAlexW2946786920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.